Early evidence, not yet clinical practice While the results are encouraging, important limitations remain
The introduction of oral GLP-1 medications is exciting because it gives patients another option, Russo said
Cannabis-responsive biomarkers provide a dynamic, high-resolution and rich feature dataset in several aspects, as shown in this study: (1) the broad range of detection levels, in which the highest detectable levels of the metabolite lactic acid were 19,000-fold higher than the oxidized glutathione acid levels on a molar basis
doi: 10.3389/fonc.2024.1414946 Received 09 April 2024 Accepted 08 July 2024 Published 22 July 2024 Volume 14 - 2024 Edited by Gaetano Gallo, Sapienza University of Rome, Italy Reviewed by Sara Claudia Barone, Sapienza University of Rome, Italy Flaminia Genualdo, Sapienza University of Rome, Italy Updates Copyright 2024 Wei, Wang, Yu, Liu and Zong
Additional research is required to further assess the safety and efficacy of CT-388 in larger, more diverse populations and to determine its long-term effects on weight management, glycemic control, and cardiovascular outcomes
See our full catalogue of research accessories
